Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-26

FDA Approved: OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved the original application for a generic combination product, olmesartan medoxomil-hydrochlorothiazide, manufactured by Novadoz Pharmaceuticals L…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Olmesartan medoxomil-hydrochlorothiazide (olmesartan medoxomil-hydrochlorothiazide)

Snippet

ORIG AP for OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE (OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE)